Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure selections remain limited. Utilize the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/ripple-gets-75m-back-as-part-of-sec-settlement-on-125m-fine/